Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis

Brain Research Bulletin
Milena RizzardiniLavinia Cantoni

Abstract

G93A Cu/Zn superoxide dismutase (SOD1), a human mutant SOD1 associated with familial amyotrophic lateral sclerosis, increased the toxicity of the mitochondrial toxin rotenone in the NSC-34 motoneuronal cell line. G93ASOD1 cells died more than untransfected and wild-type SOD1 cells after 6 and 24h exposure to 12.5 microM rotenone. Biparametric flow cytometry showed that rotenone induced rapid hyperpolarization of mitochondrial membrane potential (deltapsi(m)) in all the cell lines, followed by depolarization, and then by cell death. However, G93ASOD1 mitochondria were significantly more likely to shift from a hyperpolarized to a depolarized condition, and within the still viable cell population there was a higher proportion with depolarized mitochondria, a condition that can be envisaged as a commitment to cell death. ATP, which is needed to prevent loss of deltapsi(m), decreased more rapidly and to a greater extent in rotenone-treated G93ASOD1 cells than in the untransfected and wtSOD1cells. In all the cell lines, 1h after rotenone exposure, mitochondrial hyperpolarization was accompanied by the formation of a comparable amount of reactive oxygen species. However, G93ASOD1 cells reached the highest reactive oxygen species level...Continue Reading

References

Jul 1, 1992·Developmental Dynamics : an Official Publication of the American Association of Anatomists·N R CashmanJ P Antel
May 1, 1994·Progress in Neurobiology·M Erecińska, I A Silver
Feb 14, 1994·FEBS Letters·E J WolvetangA W Linnane
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·L J Yan, R S Sohal
May 29, 1999·The Journal of Biological Chemistry·A Barrientos, C T Moraes
Nov 27, 1999·Mechanisms of Ageing and Development·J OjaimiE Byrne
Mar 4, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·J S Isenberg, J E Klaunig
May 10, 2000·Nature Medicine·G Kroemer, J C Reed
Jun 27, 2000·Brain : a Journal of Neurology·M F Beal
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·B BeltránS Moncada
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·N Zamzami, G Kroemer
Aug 17, 2001·The Journal of Biological Chemistry·A Okado-Matsumoto, I Fridovich
Feb 19, 2002·Neurochemistry International·Fiona M MenziesPamela J Shaw
Jun 22, 2002·Brain : a Journal of Neurology·Fiona M MenziesPamela J Shaw
Feb 26, 2003·Cell·Donald D Newmeyer, Shelagh Ferguson-Miller
May 27, 2003·Biochimica Et Biophysica Acta·Bernhard Kadenbach
Aug 13, 2003·Journal of Neurochemistry·Anatoly A Starkov, Gary Fiskum
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marilena GrecoGiuseppe Attardi
Oct 22, 2003·Current Opinion in Rheumatology·Ericka P SimpsonStanley H Appel
Nov 20, 2003·The Journal of Biological Chemistry·Alexei P KudinWolfram S Kunz
May 4, 2004·Brain Research·María Francisca Molina-JiménezJuana Benedi
Jun 23, 2004·Trends in Immunology·Andras PerlKatalin Banki
Jun 26, 2004·Annual Review of Neuroscience·Lucie I BruijnDon W Cleveland
Aug 18, 2004·Trends in Molecular Medicine·Caterina Bendotti, Maria Teresa Carrì
Oct 27, 2004·Molecular & Cellular Proteomics : MCP·Kei FukadaHaining Zhu
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Chetan VijayvergiyaGiovanni Manfredi
Jul 22, 2005·Lancet Neurology·Sivakumar Sathasivam, Pamela J Shaw

❮ Previous
Next ❯

Citations

Aug 4, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Emilio L StreckJoão Quevedo
Nov 11, 2011·Journal of Bioenergetics and Biomembranes·Liesbeth Faes, Geert Callewaert
Jun 8, 2013·World Journal of Gastroenterology : WJG·Yu-Gang WangMin Shi
Apr 4, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ya-Yun HsuYi-Ching Lo
Mar 26, 2009·Neuromuscular Disorders : NMD·Russell J ButterfieldKevin M Flanigan
Oct 12, 2013·Biotechnology and Bioengineering·Simpson GregoireInchan Kwon
Jun 10, 2014·Frontiers in Cellular Neuroscience·Vedrana TadicJulian Grosskreutz
Aug 23, 2006·Nature Reviews. Neuroscience·Piera Pasinelli, Robert H Brown
Jul 10, 2007·Neurochemical Research·Aderbal S AguiarRicardo A Pinho

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.